Theratechnologies Inc
TSX:TH
Theratechnologies Inc
TSX:TH
Price:
1.73 CAD
Market Closed
Updated:
Jun 9, 2024
Theratechnologies Inc
Total Current Liabilities
|
Theratechnologies Inc
Total Current Liabilities Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Theratechnologies Inc
TSX:TH
|
Total Current Liabilities
$50.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
28%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Current Liabilities
$55.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Current Liabilities
$39.1m
|
CAGR 3-Years
53%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Current Liabilities
$16.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Current Liabilities
$71.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
61%
|
CAGR 10-Years
32%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Total Current Liabilities
CA$10.8m
|
CAGR 3-Years
55%
|
CAGR 5-Years
66%
|
CAGR 10-Years
13%
|
See Also
What is Theratechnologies Inc's Total Current Liabilities?
Total Current Liabilities
50.3m
USD
50.3m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Total Current Liabilities amounts to 50.3m USD.
What is Theratechnologies Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
28%
28%
Over the last year, the Total Current Liabilities growth was -31%. The average annual Total Current Liabilities growth rates for Theratechnologies Inc have been 9% over the past three years , 11% over the past five years , and 28% over the past ten years .
You don't have any saved screeners yet
